My best forcast estimates, which include one approval and one expansion of use, and include profitability for two recently procured businesses in three years time, is a doubling of current market cap year on year for four years. Therefore greater than $50 share price, with low risk. A couple more approvals and extension of current FDA approved products into the EU and we may see this share price in 24 months.
Low risk stock, simply hold and accumulate, it doubles, then doubles again. What a gem TLX is in the biotech space. There are 171 biotech stocks, and only about 5 worth buying unless you wish to flip a 50 sided dice and bet on a number.
My best forcast estimates, which include one approval and one...
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.49 |
Change
0.140(0.91%) |
Mkt cap ! $5.118B | |||
| Open | High | Low | Value | Volume |
| $15.38 | $15.49 | $15.04 | $9.881M | 643.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 674 | $15.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.49 | 4971 | 3 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$15.46 |
Change
0.140 ( 1.07 %) |
||||
| Open | High | Low | Volume | ||
| $15.40 | $15.49 | $15.06 | 121022 | ||
| Last updated 15.59pm 10/05/2024 ? | |||||
| TLX (ASX) Chart |